Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 193

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 193
---
 such payment will pay
to the Exchange Agent any transfer or tax required as a result of such payment to a Person other than the registered holder of such Stock Certificate or establish to the satisfaction of the Exchange Agent that such tax has been paid or is not
payable.

Any portion of the Payment Fund that remains unclaimed by the holders of Eligible Shares one year after the Effective Time will
be delivered to the Surviving Corporation, upon demand, and any such holder who has not exchanged Eligible Shares for the Merger prior to that time will thereafter look only to the Surviving Corporation and the Surviving LLC for payment of the
Merger Consideration.

Treatment of Enfusion Equity Awards and Employee Stock Purchase Plan

Treatment of Stock Options

Each In-the-Money Enfusion Option, whether vested or unvested, that is outstanding and unexercised will be cancelled immediately prior to the Effective Time in exchange for the
right of the holder to receive an amount in cash equal to the product of (i) the number of shares of Enfusion Common Stock subject to such In-the-Money Enfusion
Option immediately prior to the Effective Time, multiplied by (ii) the excess of the Per Share Cash Consideration over the exercise price of such In-the-Money
Enfusion Option, less applicable tax withholding. Each Out-of-the-Money Enfusion Option that is outstanding and unexercised will
be cancelled immediately prior to the Effective Time for no consideration.

Treatment of Restricted Stock Units

Each Enfusion Vested RSU will be cancelled at the Effective Time in exchange for the right of the holder to receive the per share Merger
Consideration in respect of each share of Enfusion Common Stock subject to such Enfusion Vested RSU immediately prior to the Effective Time, less applicable tax withholding, in the form determined at the election of the holder in accordance with the
procedures described above under the section titled “The Transactions—Merger Consideration.”

Each Enfusion Unvested RSU
will be assumed by Clearwater and converted at the Effective Time into an Assumed RSU, subject to the same terms and conditions as applied to the Enfusion Unvested RSU immediately prior to the Effective Time. The number of shares of Clearwater
Common Stock subject to each Assumed RSU will be equal to the product (rounded up to the nearest whole share) of (i) the number of shares of Enfusion Common Stock subject to the corresponding Enfusion Unvested RSU immediately prior to the